Flashpoint Therapeutics
PrivateLast Round
Seed
Oct 25, 2023
Est. Valuation
$35M
Total Funding Raised
$20M
Company Overview
Flashpoint Therapeutics is a biotechnology company that develops precision-engineered structural nanomedicines for cancer and other diseases by co-delivering RNA, DNA, and peptide cargo to specific cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flashpoint Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Flashpoint Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 25, 2023 | ||||
| Seed | Oct 25, 2023 | ||||
| Pre Seed | Jan 30, 2023 |
Key People
Founding team and executive leadership
Flashpoint Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beta Lab | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2025
Barry Labinger appointed as new Chief Executive Officer.
Flashpoint Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Flashpoint Therapeutics's valuation, stock price, and market status.